Abstract
Survival in liver transplant (LT) recipients is lower than matched controls,1Click or tap here to enter text. and cardiovascular disease (CVD) is the key contributor to this increased mortality.2 Given the central role of liver in lipoprotein metabolism, perturbation in normal physiological functions that occur with chronic liver disease (CLD), is associated with production of atherogenic lipoproteins such as small dense low-density lipoproteins (LDLs) (sdLDLs), which is associated with increased risk of atherosclerotic events in LT recipients and CLD.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
